Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Bamberg

Showing results (111-120 of 122) with videos related to

Pageof 13
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2006
Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03Ulrich Herrlinger, Johannes Rieger, Dorothee Koch, et al.
Annals of Neurology|June 29, 2011
NOA-05 phase 2 trial of procarbazine and lomustine therapy in gliomatosis cerebriMartin Glas, Oliver Bähr, Jörg Felsberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2010
Phase II trial of a trimodality regimen for stage III non-small-cell lung cancer using chemotherapy as induction treatment with concurrent hyperfractionated chemoradiation with carboplatin and paclitaxel followed by subsequent resection: a single-center studyGodehard Friedel, Wilfried Budach, Juergen Dippon, et al.
Annals of Neurology|February 9, 2002
German Cancer Society Neuro-Oncology Working Group NOA-03 multicenter trial of single-agent high-dose methotrexate for primary central nervous system lymphomaUlrich Herrlinger, Martin Schabet, Wolfram Brugger, et al.
Neurology|February 27, 2015
Randomized phase III study of whole-brain radiotherapy for primary CNS lymphomaAgnieszka Korfel, Eckhard Thiel, Peter Martus, et al.
The Lancet. Oncology|October 26, 2010
High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trialEckhard Thiel, Agnieszka Korfel, Peter Martus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 2009
NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomideWolfgang Wick, Christian Hartmann, Corinna Engel, et al.
Neuro-Oncology|July 3, 2016
Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomideWolfgang Wick, Patrick Roth, Christian Hartmann, et al.
Neuro-Oncology|February 18, 2020
Superiority of temozolomide over radiotherapy for elderly patients with RTK II methylation class, MGMT promoter methylated malignant astrocytomaAntje Wick, Tobias Kessler, Michael Platten, et al.
European Journal of Cancer (Oxford, England : 1990)|January 19, 2023
Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ductal adenocarcinoma: The HEAT randomised clinical trialRolf D Issels, Stefan Boeck, Uwe Pelzer, et al.
Pageof 13

Showing results (111-120 of 122) with videos related to

Sort By:
Pageof 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2006
Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03Ulrich Herrlinger, Johannes Rieger, Dorothee Koch, et al.
Annals of Neurology|June 29, 2011
NOA-05 phase 2 trial of procarbazine and lomustine therapy in gliomatosis cerebriMartin Glas, Oliver Bähr, Jörg Felsberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2010
Phase II trial of a trimodality regimen for stage III non-small-cell lung cancer using chemotherapy as induction treatment with concurrent hyperfractionated chemoradiation with carboplatin and paclitaxel followed by subsequent resection: a single-center studyGodehard Friedel, Wilfried Budach, Juergen Dippon, et al.
Annals of Neurology|February 9, 2002
German Cancer Society Neuro-Oncology Working Group NOA-03 multicenter trial of single-agent high-dose methotrexate for primary central nervous system lymphomaUlrich Herrlinger, Martin Schabet, Wolfram Brugger, et al.
Neurology|February 27, 2015
Randomized phase III study of whole-brain radiotherapy for primary CNS lymphomaAgnieszka Korfel, Eckhard Thiel, Peter Martus, et al.
The Lancet. Oncology|October 26, 2010
High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trialEckhard Thiel, Agnieszka Korfel, Peter Martus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 2009
NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomideWolfgang Wick, Christian Hartmann, Corinna Engel, et al.
Neuro-Oncology|July 3, 2016
Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomideWolfgang Wick, Patrick Roth, Christian Hartmann, et al.
Neuro-Oncology|February 18, 2020
Superiority of temozolomide over radiotherapy for elderly patients with RTK II methylation class, MGMT promoter methylated malignant astrocytomaAntje Wick, Tobias Kessler, Michael Platten, et al.
European Journal of Cancer (Oxford, England : 1990)|January 19, 2023
Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ductal adenocarcinoma: The HEAT randomised clinical trialRolf D Issels, Stefan Boeck, Uwe Pelzer, et al.
Pageof 13